Continuing the discussion from Compound Tirzepatide and Semaglutide: Transparency in FDA Drug Shortage Process & 503b Protection:
We need PBM reform stat!! Their greed is preventing too many Americans from being able to afford the exorbitant GLP-1 prices. We also need the manufacturers to lower their prices. Zepbound is between $550 & $650 with a savings card. For most of us, that’s unattainable on a monthly basis. I’m a state employee but my insurance does not cover weight loss meds. They wld rather wait until I get a disease which is ridiculous bc they’d end up paying more for my treatment. Absolutely counter-intuitive! Allow the compounders to produce the meds bc it’s at least somewhat affordable, although still expensive. Lastly, the manufacturers need to release the vials in ALL doses! Not everyone can tolerate titrating up at such high jumps in dose. Let us have control over how slow we go up in dose. That’s why I prefer the compound over the pens.